Intercept Pharmaceuticals, Inc. (ICPT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 16.85 |
| Open | 16.67 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 1200 |
| Day's range | 16.08 - 16.89 |
| 52-week range | 10.81 - 20.50 |
| Volume | |
| Avg. volume | 806,579 |
| Market cap | 496.435M |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Intercept (ICPT) Earnings Miss, Sales Top Estimates in Q2 (Revised)
Intercept (ICPT) posts a wider Q2 loss while sales beat estimates. The company reissues guidance.
- Zacks
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Beats Revenue Estimates (Revised)
Intercept (ICPT) delivered earnings and revenue surprises of -28.30% and +5.86%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Intercept (ICPT) Earnings and Sales Miss Estimates in Q2
Intercept (ICPT) posts a wider Q2 loss and sales miss estimates. The company reissues guidance.
© 2022 Yahoo. All rights reserved.
